Antibiotic resistance of Escherichia coli isolated from dairy cow milk associated with subclinical mastitis in the Licin Subdistrict, East Java, Indonesia.
Saved in:
| Title: | Antibiotic resistance of Escherichia coli isolated from dairy cow milk associated with subclinical mastitis in the Licin Subdistrict, East Java, Indonesia. |
|---|---|
| Authors: | Praja, Ratih Novita1,2 ratihnovitapraja@fkh.unair.ac.id, Yudhana, Aditya1,2, Pratama, Lingga Dwi3, Pratiwi, Erliza Kusuma1, Herina, Rizky Bedzy1, Setyarini, Devia Wahyu1, Sholiha, Alfi Hidayatus1, Fuadil, Sholeh Hafish Ahmad1, Khairunisa, Fitri1 |
| Source: | Open Veterinary Journal. 2025, Vol. 15 Issue 11, p6009-6019. 11p. |
| Document Type: | Article |
| Subjects: | Escherichia coli, Mastitis, Indonesians, Drug resistance in bacteria, Dairy cattle |
| Geographic Terms: | Indonesia, Jawa Timur (Indonesia) |
| Author-Supplied Keywords: | Antimicrobial resistance Infectious disease Public health Raw milk |
| Abstract: | Background: The incidence of bacterial resistance is a serious global health concern because it reduces the effectiveness of antibiotics and complicates the treatment of infectious diseases. Mastitis is one of the most common and economically significant diseases in the dairy industry, leading to reduced milk yield, altered milk quality, and financial losses for farmers. Antibiotics are commonly used for mastitis treatment, but their excessive or inappropriate use can accelerate the development of antimicrobial resistance (AMR). Escherichia coli, a major foodborne pathogen, is also recognized as an important causative agent of bovine mastitis, with contamination often originating from milk and dairy products. Aim: This study investigated the antimicrobial resistance of E. coli isolated from dairy cows with subclinical mastitis in the Licin Subdistrict to provide information on suitable antimicrobial treatment for mastitis. Methods: Exploratory laboratory research was conducted using purposive sampling. Milk samples from lactating Holstein Friesian dairy cows were screened for subclinical mastitis using the California mastitis test (CMT). Samples with CMT scores of +++ and ++++ were processed for E. coli isolation using eosin methylene blue agar, Gram staining, and Indole, Methyl Red, Voges Proskauer, and Citrate biochemical tests. Resistance testing against different antibiotics was conducted using the Kirby--Bauer disc diffusion technique. Results: A total of 29 milk samples were examined; 17 (58.6%) samples tested positive for subclinical mastitis. Among the 17 subclinical mastitis-positive samples, 4 (23.5%) were positive for E. coli. Antibiotic resistance testing of the E. coli isolates showed 100%, 25%, and 25% resistance to erythromycin, tetracycline, and streptomycin, respectively. All E. coli isolates (100%) were sensitive to aztreonam, chloramphenicol, trimethoprim, and ciprofloxacin. Conclusion: The antibiotic resistance patterns observed in E. coli isolates pose significant challenges for mastitis treatment in dairy farms. Although complete resistance to erythromycin limits therapeutic options, the maintained sensitivity to aztreonam, chloramphenicol, trimethoprim, and ciprofloxacin provides viable alternatives. These findings emphasize the importance of antimicrobial stewardship and routine resistance monitoring to preserve effective treatment options and ensure sustainable dairy production. [ABSTRACT FROM AUTHOR] |
| Copyright of Open Veterinary Journal is the property of Open Veterinary Journal and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Author Affiliations: | 1Veterinary Medicine Study Program, Department of Health, Medicine and Life Sciences, Faculty of Health, Universitas Airlangga, Banyuwangi, Indonesia 2Research Group for Animal Biomedical and Conservation, Universitas Airlangga, Banyuwangi, Indonesia 3Veterinary Medicine Study Program, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia |
| ISSN: | 2226-4485 |
| DOI: | 10.5455/OVJ.2025.v15.i11.55 |
| Accession Number: | 191964509 |
| Database: | Veterinary Source |
| Abstract: | Background: The incidence of bacterial resistance is a serious global health concern because it reduces the effectiveness of antibiotics and complicates the treatment of infectious diseases. Mastitis is one of the most common and economically significant diseases in the dairy industry, leading to reduced milk yield, altered milk quality, and financial losses for farmers. Antibiotics are commonly used for mastitis treatment, but their excessive or inappropriate use can accelerate the development of antimicrobial resistance (AMR). Escherichia coli, a major foodborne pathogen, is also recognized as an important causative agent of bovine mastitis, with contamination often originating from milk and dairy products. Aim: This study investigated the antimicrobial resistance of E. coli isolated from dairy cows with subclinical mastitis in the Licin Subdistrict to provide information on suitable antimicrobial treatment for mastitis. Methods: Exploratory laboratory research was conducted using purposive sampling. Milk samples from lactating Holstein Friesian dairy cows were screened for subclinical mastitis using the California mastitis test (CMT). Samples with CMT scores of +++ and ++++ were processed for E. coli isolation using eosin methylene blue agar, Gram staining, and Indole, Methyl Red, Voges Proskauer, and Citrate biochemical tests. Resistance testing against different antibiotics was conducted using the Kirby--Bauer disc diffusion technique. Results: A total of 29 milk samples were examined; 17 (58.6%) samples tested positive for subclinical mastitis. Among the 17 subclinical mastitis-positive samples, 4 (23.5%) were positive for E. coli. Antibiotic resistance testing of the E. coli isolates showed 100%, 25%, and 25% resistance to erythromycin, tetracycline, and streptomycin, respectively. All E. coli isolates (100%) were sensitive to aztreonam, chloramphenicol, trimethoprim, and ciprofloxacin. Conclusion: The antibiotic resistance patterns observed in E. coli isolates pose significant challenges for mastitis treatment in dairy farms. Although complete resistance to erythromycin limits therapeutic options, the maintained sensitivity to aztreonam, chloramphenicol, trimethoprim, and ciprofloxacin provides viable alternatives. These findings emphasize the importance of antimicrobial stewardship and routine resistance monitoring to preserve effective treatment options and ensure sustainable dairy production. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 22264485 |
| DOI: | 10.5455/OVJ.2025.v15.i11.55 |